Answers are grounded in this paper and cite their sources.
Glucagon promotes hepatic glucose production, lipolysis and amino acid catabolism. Inhibition of glucagon activity, or glucagon resistance, not only lowers blood glucose levels, but also induces non-alcoholic fatty liver disease and hyperaminoacidemia.
No takes yet. Share an insight, caveat, or question.
Yoshitaka Hayashi (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: